FDA 483 - PCAS Finland Oy - June 07, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of PCAS Finland Oy, an API manufacturer in Turku, Finland, revealed significant deficiencies in quality control and facility maintenance. The firm failed to investigate unknown impurities in its Active Pharmaceutical Ingredient (API) using an in-house analytical method and lacked established maintenance procedures for critical manufacturing equipment. Additionally, the inspection found poor repair and maintenance of manufacturing spaces and equipment in bioburden-controlled areas, including holes in exhaust vents and compromised air intake vents.
ID · d2b356c4-7b1c-4bd8-aafc-d3b75e123c49